HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

DL-Dopa

HCID 836
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
5796-17-8
Standard SMILES
NC(Cc1ccc(O)c(O)c1)C(=O)O
InChIKey
WTDRDQBEARUVNC-UHFFFAOYSA-N
Molecular formula
C9H11NO4
Average molar mass
197.19 g/mol
Monoisotopic mass
197.06880783

Overview

Dopa is a hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring. It has a role as a human metabolite. It is a hydroxyphenylalanine, a tyrosine derivative and a non-proteinogenic alpha-amino acid.

Names & identifiers

Preferred name
DL-Dopa
IUPAC
2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
English name
D-DOPA
Molecular formula
C9H11NO4
Molecular weight
197.19

Names & synonyms

DL-DOPA63-84-32-Amino-3-(3,4-dihydroxyphenyl)propanoic aciddihydroxyphenylalanineDL-Dioxyphenylalanine3-Hydroxy-DL-tyrosineDL-3,4-Dopa(+-)-DopaDL-beta-(3,4-Dihydroxyphenyl)alanine(+-)-3-(3,4-Dihydroxyphenyl)alanineQI9C343R60NSC-16940
Show more names
Levodopa Impurity D3,4-DIHYDROXY-D-PHENYLALANINE(R)-2-AMino-3-(3,4-dihydroxyphenyl)propanoic acidD-DOPADextrodopaD-DOPA USP/EP/BP3-HydroxytyrosineD-3-HYDROXYTYROSINE3-HYDROXY-D-TYROSINEH-D-TYR(3-HYDROXY)-OH
DOPA, DL-ALANINE, 3-(3,4-DIHYDROXYPHENYL)-, DL-DTXSID8020549CHEBI:491683 Hydroxy DL tyrosinebeta HydroxytyrosineRefChem:5899393,4 Dihydroxyphenylalanine

Database identifiers

CAS
5796-17-8、63-84-3
PubChem CID
836
DTXSID
DTXSID8020549
ChEMBL

Properties

Computed structural properties

XLogP
-2.7
Topological polar surface area
104 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
5
Rotatable bonds
3
Heavy atoms
14
Formal charge
0
Complexity
209

Experimental & physicochemical properties

Chemical ClassesBiological Agents -> Amino Acids and Derivatives
DrugsPharmaceuticals
Solubility3.6 mg/mL
Melting Point270 °C
Physical Description · 2 items

Solid; [Merck Index] White solid; [Sigma-Aldrich MSDS]

Solid

Dissociation Constants2.21

Physicochemical properties

Melting point
276 · 276-278 °C(lit.)
alpha
11 · D11 +13.0° (c = 5.27 in 1N HCl)
Boiling point
448.4 · 448.4±45.0 °C(Predicted)
Density
1.468 · 1.468±0.06 g/cm3(Predicted)
storage temp.
-20 °C · -20°C
solubility

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (16.7%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 48 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationChemical: DL-Tyrosine, 3-hydroxy-
Hazards SummaryA skin and strong eye irritant; [Sigma-Aldrich MSDS] See Levodopa.
Hazard Classes and CategoriesAcute Tox. 4 (16.7%)

Toxicology

Treatment · 2 items

Hospitalization is advised, and general supportive measures should be employed, along with immediate gastric lavage and repeated doses of charcoal over time. This may hasten the elimination of entacapone in particular, by decreasing its absorption/reabsorption from the GI tract. Intravenous fluids should be administered judiciously and an adequate airway maintained. The adequacy of the respiratory, circulatory and renal systems should be carefully monitored and appropriate supportive measures employed. Electrocardiographic monitoring should be instituted and the patient carefully observed for the development of arrhythmias; if required, appropriate antiarrhythmic therapy should be given. The possibility that the patient may have taken other drugs, increasing the risk of drug interactions (especially catechol-structured drugs) should be taken into consideration. Hemodialysis or hemoperfusion is unlikely to reduce entacapone levels due to its high binding to plasma proteins. (L1712)

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 2 items

95% of an administered oral dose of levodopa is pre-systemically decarboxylated to dopamine by the L-aromatic amino acid decarboxylase (AAAD) enzyme in the stomach, lumen of the intestine, kidney, and liver. Levodopa also may be methoxylated by the hepatic catechol-O-methyltransferase (COMT) enzyme system to 3-O-methyldopa (3-OMD), which cannot be converted to central dopamine. Half Life: 50 to 90 minutes

Uremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.

MeSH Pharmacological ClassificationAny drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.
Cellular LocationsCytoplasm

Uses & manufacturing

Uses · 4 items

Dopa is an amino acid in the seedlings, pods, and beans of broad beans and velvet beans; [Merck Index]

Use (kg) in Switzerland (2009): >2500

For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication.

Naturally produced by the body (endogenous).

Applications

UsesD-DOPA (Levodopa EP Impurity D) is a DOPA enantiomer that lacks biological activity.

UsesA DOPA enantiomer that lacks biological activity.

Additional notes

ChEBI: The D-enantiomer of dopa.

Related reactions

10 records
New reaction record
HRID 176932 reaction equation
HRID 176932As reactant
HRID 203066 reaction equation
HRID 203066As reactant
HRID 282565 reaction equation
HRID 282565As reactant
HRID 543233 reaction equation
HRID 543233As reactant
HRID 1032885 reaction equation
HRID 1032885As product
HRID 1153526 reaction equation
HRID 1153526As reactant
HRID 1202904 reaction equation
HRID 1202904As reactant
HRID 1205047 reaction equation
HRID 1205047As reactant
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CHEMBL351042
ChEBI
CHEBI:49168
UNII
QI9C343R60
EC Number
200-566-0
Nikkaji
J128.150J
0.5 M · 0.5 M HCl: soluble
form
powder
pka
2.24 · 2.24±0.20(Predicted)
color
white to tan
Merck
13 · 13,3454
BRN
2417637 · 2417637
Stability
Hygroscopic
InChI
InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m1/s1
InChIKey
WTDRDQBEARUVNC-ZCFIWIBFSA-N
SMILES
C(O)(=O)[C@@H](CC1=CC=C(O)C(O)=C1)N
CAS DataBase Reference
5796 · 5796-17-8(CAS DataBase Reference)
FDA UNII
8 T862R29FY · 8T862R29FY
UNSPSC Code
12352209 · 12352209
NACRES
32 · NA.32
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H335-H319
Precautionary statements
264 · P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P
PPE
95 · Eyeshields, Gloves, type N95 (US)
WGK Germany
3 · 3
F
10 · 10-23
HS Code
2922500090 · 2922500090
Storage Class
11 · 11 - Combustible Solids

Kidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.

Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure Routes · 2 items

Levodopa is rapidly absorbed from the proximal small intestine by the large neutral amino acid (LNAA) transport carrier system.

Endogenous, Ingestion, Dermal (contact)

Toxicity Summary · 2 items

Striatal dopamine levels in symptomatic Parkinson's disease are decreased by 60 to 80%, striatal dopaminergic neurotransmission may be enhanced by exogenous supplementation of dopamine through administration of dopamine's precursor, levodopa. A small percentage of each levodopa dose crosses the blood-brain barrier and is decarboxylated to dopamine. This newly formed dopamine then is available to stimulate dopaminergic receptors, thus compensating for the depleted supply of endogenous dopamine.

Uremic toxins such as dihydroxyphenylalanine are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

Signs and Symptoms · 1 item

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen Classification · 2 items

No indication of carcinogenicity to humans (not listed by IARC).

No indication of carcinogenicity to humans (not listed by IARC).

Toxicity DataLD50: 2363 mg/kg (Oral, Mouse) (A308) LD50: 609 mg/kg (Oral, Rabbit) (A308) LD50: 1780 mg/kg (Oral, Rat) (A308)

Safety data

F
10-23
PPE
Eyeshields, Gloves, type N95 (US)
wgk
3
hs_code
2922500090
Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
11 - Combustible Solids
Hazard statements
H315-H335-H319
Precautionary statements
P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P
Definition